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Abstract 
Animal contain stem cells in different parts of body that are involved in regeneration and repair process but regeneration and repair 
capacity of different animals is different. Stem cells can be classified on the basis of origin, potential of differentiation and cell 
surface markers. In addition to embryonic stem cells (ESCs), bone marrow derived mesenchymal stem cells (MSCs), circulating 
blood stem cells and umbilical cord blood stem cells are major source of stem cells for therapeutic purposes. Adipose derived MSCs 
have also proved to be rich and therapeutically important source of stem cells. Animal during lifetime suffer from various diseases 
that are treated by different therapeutical ways. With the advancement in research in area of stem cell biology, it provides a better 
alternative to treat several diseases including life threatening diseases. We provided information about current therapeutically 
potentials and future prospective of stem cells therapy in veterinary medicine. We collected information about stem cell research in 
various animals from peer reviewed journals using standard database. Stem cells therapy treat orthopedic lesions, disc 
regeneration, osteoarthritis, repair of cranial bone defects, cartilage defects, corneal stroma, tendon repair, ligament injury, liver 
injury, nerve regeneration etc. in various animals. Now a day’s extensive research work is going in area of stem cells research in 
USA, Europe, Middle East and Asia. In future, stem cells therapy bears a scope to treat broad spectrum of animals ranging from rat, 
cats, and dogs to food and milk producing animals like goat, sheep, cow and buffaloes.  
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INTRODUCTION 
Animals have ability to regenerate some parts of body 
which are accidentally lost i.e. tail of lizard during their 
course of life. Moreover repairing of body cells and tissues 
is normal phenomena both in animals and human. But 
variation in this regeneration process is seen in case of 
vertebrate and invertebrates; as invertebrates like hydra 
can regenerate whole tissue in rapid and precise manner 
while antler and liver regeneration in case of elks and 
human are examples of organ regeneration, healing of 
wounds is another example of regeneration in higher 
vertebrates. These tissue regeneration processes are done 
via activation of pre-existing stem cells or progenitor cells in 
body (Brockes, 1997).  Due to this, research on ability of 
regeneration in living things through series of 
experimentations, scientists were able to recognize stem 
cells in different organs of body. It results in the 
development of different therapeutic approaches like bone 
marrow transplantation. Now-a-days scientists are involved 
in identification, extraction and potentially usage of different 
types of stem cells for therapeutic purpose.  Stem cells are 
defined as cells that have the ability to self-renew as well 
can differentiate in different mature cells like hepatocytes, 
myocytes, neurons etc. In early embryos all cells are 
totipotent stem cells, as they have the ability to form all 
tissues of the organism. There are also stem cells in adult 
tissues that contribute to the renewal and regeneration of 
specific tissues. 
In recent times, researchers have also discovered 
stem cells in umbilical cord and placenta. These stem cells 
have the ability to differentiate into all blood cells. 
Embryonic stem cells (ESCs) can be achieved from in vitro 
fertilization (IVF) and Somatic Cell Nuclear Transfer 
(SCNT) while adult stem can be affectively isolated from 
adult tissues of body. Three potential sources of stem cells 
to apply for transplants are bone marrow, the bloodstream, 
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and umbilical cord blood. Bone marrow of the pelvis area 
has an affluent source of stem cells and used most 
frequently for bone marrow transplant. Usually, a small 
number of stem cells are found in the blood, the stem cells 
are usually activated to harvest them from circulating blood. 
Umbilical cord blood can be an additional possible source 
of stem cells. The above mentioned three sources of stem 
cells can be used for the similar objective like to treat the 
patients suffering from different diseases. Here might be 
few controversies to each source; however every source is 
generally capable to supply the desired number of stem 
cells for treatment options. In addition to adult stem cells 
single blastomere can be used for isolation of ESCs 
(Klimanskaya et al., 2006). The inner cell mass (ICM) of 
blastocyst is the most common source of ESCs. For this 
purpose blastocyst can be produced in vivo and in vitro by 
insemination, direct sperm injection, SCNT and IVF 
(Klimanskaya et al., 2005; Amit and Itskovitz-Eldor, 2006; 
Fletcher et al., 2006). Induced Pluripotent stem cells 
(iPSCs) from different cell types (fibroblasts, hepatocytes 
etc.) had been produced by transfection of gene coding for 
Oct3/4, Sox2, c-Myc and Klf4 using similar cultural 
conditions as for ESCs (Takahashi and Yamanaka, 2006; 
Okita et al., 2007; Wernig et al., 2007) and these can be 
used as an alternative source of ESCs with minimal ethical 
issues.  
Different strategies are used for the isolation of 
embryonic and adult stem cells from their sources for 
therapeutical purpose. Different approaches like 
mechanical dissection, immuno-selection are used for 
isolation of ICM from blastocyst in case of ESCs isolation. 
Adult stem cells are isolated from their sources by using 
mechanical digestion, enzymatic digestion, mononuclear 
cell fraction and centrifugation (Thomson et al., 1998; Koch 
et al., 2007). After isolation from blastocyst, culture and 
expansion of ICM can be achieved in tissue culture dish or 
petri plates having a mitotically inactivated feeder cell layer. 
But there are different views of scientist for the use of 
feeder layer and animal sera for culturing and expansion of 
ESCs. Contrary to ESCs, adult stem cells (ASCs) do not 
require feeder layer, they can be directly plated on plastic 
culture flasks or dish having material like polystyrene (Kang 
et al., 2005; Amit and Itskovitz-Eldor, 2006; Fletcher et al., 
2006). 
In case of stem cells like adipose derived-MSCs, 
angiogenesis and neovascularization is accelerated by 
secretion of cytokines such as hepatic growth factor (HGF), 
vascular endothelial growth factor (VEGF), placental 
growth factor (PGF), transforming growth factors-Beta 
(TGFβ), fibroblast growth factor (FGF-2) and angiopoietin 
and have been assisted by endothelial progenitor cells 
(Nakagami et al., 2006). Stem cells shows diverse 
plasticity, which mean these cells, can be differentiate into 
adipose tissue, bone, cartilage, muscles, cardiac, neuron 
and hematopoietic lineage and this differentiation potential 
have been experimentally proved in vitro and animal 
models. Diseases in different animals like rabbits (Oliveira 
et al., 2010), horses (MacLean et al., 2012; Young, 2012), 
Caprine (Murphy et al., 2003; Azari et al., 2011), dogs 
(Zhao et al., 2012) and mice (Cheng et al., 2010) were 
treated by stem cell therapy. These cells like others 
progenitor cells can target distinctively their pathological 
area, when administrated into body via intravenous and 
parenteral routes due to their precise ability of chemotaxis, 
which help in migration of stem cells toward distant target 
sites (Chen et al., 2001). Apart from these properties stem 
cell also have ability of revascularization, anti-apoptosis etc. 
which make stem cell a powerful candidate for therapy of 
veterinary diseases. Although stem cells research is 
focused on laboratory and large animals worldwide 
(Harding et al., 2013; Khan et al., 2013), recently, apart 
from goat (Dubey et al., 2013), buffalo (Black gold of 
Pakistan) is also included in this list (Puri et al., 2012; 
Sharma et al., 2013) in India. In present review, the current 
therapeutically potentials and future prospective of stem 
cells therapy in various animals is discussed. 
  
Types of stem cells 
Stem cells can be differentiated on the basis of 
different potential paths, including their potency, origin and 
cell surface markers. With respect to potency of 
differentiation of stem cell, they are divided into three types 
including totipotent stem cell, pluripotent stem cell and 
multipotent stem cell. Totipotent stem cells are cells which 
can give raise every type of cell of body as well as 
complete organism. Cells from premature embryonic 
stages and zygote are considered as totipotent in their 
potency. While stem cells that can give raise any type of 
tissue but they cannot give rise a complete functional 
organism are known as pluripotent stem cells. They can 
form all cells of the body except trophoblast. ESCs are 
example of pluripotent stem cells as they can differentiate 
into cells of three germ layers. Third types of stem cells are 
more differential, so that they give rise only partial number 
of tissues or cell types. Mesenchymal stem cells are an 
excellent example of multipotent stem cells which contain 
classic trilineage segregation potential to chondrogenic, 
adipogenic and osteogenic pedigree (Koch et al., 2008). 
Stem cell with respect to their source of origin can 
divide them in two major types including embryonic stem 
cell and adult stem cells. ESCs are isolated from morulla or 
inner cell mass (ICM) of blastocyst of mammals while 
ASCs are localized in different parts of an organisms e.g. 
brain, liver, intestinal tissues, skin etc. ESCs can be 
produced by IVF, SCNT and more recently by forced 
expression of embryonic stem cells related gene in mature 
cells and are called iPSC. Moreover, most of the 
information related to ESCs came from two fields of 
investigation i.e. applied reproductive biology like IVF and 
fundamental research on mouse embryology. With the 
advancement in research related to stem cells, new 
concept are coming as in case of ASCs, a new term 
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plasticity of ASCs is used, which mean it was considered 
commonly that hematopoietic stem cells from bone marrow 
can only be converted into blood and immune cells. But, 
now stem cell scientists are able to develop neurons and 
cells commonly found in brain from adult stem cells. Apart 
from division base on potency and origin, stem can be 
differentiate with respect to presence of surface markers 
like CD34, CD45, CD90, CD105, CD73, CD14, CD11b, 
CD79 and HLA-DR. As CD14, CD34 and CD45 are 
surface markers recognized on MSCs (Tyndall et al., 
2007). 
 
Stem cells in animals 
Stem cell therapy have vast application in animals 
especially in equine and canine family, apart from these 
other animals including sheep, goat, monkey, duck, golden 
hamster, pig, swine, rat, rabbit etc are used as laboratory 
animal to explore more treatment regimens for human 
being as well. MSC alone and in combination with Insulin-
Like Growth Factor-I Gene (AdIGF) results in optimal 
improvement in injured tendon histological score both in 
experimental and impulsive lesions in equine (Smith et al., 
2003; Schnabel et al., 2009). But some controversies have 
been seen with MSCs treatment, as in case of long term 
histological look or biochemical composition of cartilage 
lesions did not considerably improved in equine model 
while major healing has been seen at early stage in same 
animal (Wilke et al., 2007). Autologous peripheral blood 
derived MSCs have been found to be affective for 
treatment of chronic degenerative joint disease (DJD) in 
horse (Spaas et al., 2012). The effect of cell therapy 
products [adipose-derived stromal vascular fraction (SVF), 
bone marrow mononuclear cells (BMMNs), cord blood 
mononuclear cells (CBMNs) and platelet rich plasma] on 
MSCs function were studies in horse for acute orthopedic 
lesions treatment in vitro. They found all cell therapy 
product play role in proliferation of MSCs, while SVF play 
most significant role (Kol et al., 2012). In a recent research 
on equine bone marrow, MSCs reported these stem cells 
can be proved as positive applicant for cell therapy in game 
animals (Adams et al., 2012). Moreover, in recent study 
silica nano-particles were found as a very good labeling 
maker for canine Mesenchymal stem cells and this 
approach can be used for distribution and fate of 
transplanted MSCs (Han et al., 2012). 
 
Animal diseases potential candidates for stem cells 
therapy 
Although there are several animals’ diseases which 
can be treated with stem cell therapy, however, following 
are the few important veterinary diseases that can be 
treated with different types of stem cells as given in table 1. 
 
 
Table1. List of animals’ diseases can be treated with stem cell therapy. 
Animal 
Type 
Stem Cell Type Disease/Disorder Treated Reference 
Dogs/ 
Canine 
Mesenchymal stem cells (MSCs) Canine Disc Degeneration Serigano et al., 2010 
Autologous adipose-derived (AD-D)-MSCs Chronic osteoarthritis Guercio et al., 2012 
Bone marrow MSC associated with rhBMP2 Osteosarcoma Rici et al., 2012 
AD-D Mesenchymal Stem and Regenerative 
Cells 
Chronic Osteoarthritis Black et al., 2008 
Adipose-derived MSCs Peri-ocular and joint diseases Wood et al., 2012 
Allogenic muscle stem cells Duchenne-muscular dystrophy Rouger et al., 2011 
Adipose derived stem cells and coral scaffold Repair of cranial bone defects Cui  et al., 2007 
Rabbits Autologous bone-marrow derived 
mesenchymal cell 
Articular cartilage defects Yanai et al., 2005 
MSCs Large osteochondral defect Tatebe et al., 2005 
Human MSCs Incisional wound repair anterior Alexander et al., 2009 
MSCs or PDGF-B gene-transfected MSCs Cruciate ligament reconstruction Feng et al., 2007 
Adipose-Derived Stem Cells Therapy of the Corneal Stroma Francisco et al., 2008 
Fetal rabbit liver MSCs (fl-MSCs) Congenital birth defects Moreno et al., 2012 
Infra-patellar fat pad derived MSCs Osteoarthritis Toghraie et al., 2011 
Horses Autologous equine MSCs Superficial digital flexor tendon Smith et al., 2003 
Fetal derived embryonic-like stem cells (fdESC) Tendonitis Watts et al., 2011 
Arthroscopic MSCs Articular Defects Wilke et al., 2007 
Bone marrow mononucleated cells (BMMNCs) Musculoskeletal overuse injuries Torricelli et al., 2011 
Bone marrow-derived MSCs (BMSCs) Chondral defects McIlwraith et al., 2011 
Rat/ 
Mice 
Allogeneic MSCs Femoral segmental defect Tsuchida et al., 2003 
Mesoangioblasts Alpa-sarcogycan null dystrophy Sampaolesi et al., 2003 
Multipotent cell population from human adipose Dystrophin expression Rodriguez et al., 2005 
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tissue 
Allogeneic Bone Marrow MSCs Collagen-Induced Arthritis Augello et al., 2007 
Bone-marrow stromal cells Sciatic nerve regeneration Dezawa et al., 2001 
Adult bone marrow stromal cells Traumatic brain injury Lu et al., 2001 
Allogeneic bone marrow-derived mesenchymal 
stromal cells 
Injured skeletal muscle Natsu et al., 2004 
Autologous bone marrow cell therapy Ischemia-induced angiogenesis Claudio et al., 2005 
Skin-Derived Stem Cells Nerve Regeneration Marchesi et al., 2007 
Bone marrow stromal cell-derived Schwann 
cells 
Nerve regeneration Mimura et al., 2004 
Bone marrow MSCs Nerve regeneration Tohill et al., 2004 
Hematopoietic stem cell gene therapy Neurological abnormalities Miranda et al., 2000 
MSCs Acute myocardial infarction Shyu et al., 2006 
Adult stem cells Bone Healing Lee et al., 2009 
MSCs Therapy of Diabetes Urban et al., 2008 
MSCs Obstructive sleep apnea Carreras et al., 2010 
Hematopoietic stem cell transplantation Lethal stroke Felfly et al., 2010 
Sheep/ 
Goat 
Autologous MSCs Large articular cartilage defects Guo et al., 2004 
MSCs Bone regeneration Niemeyer et al., 2010 
Epidermal Adult Stem Cells AFTSD* and LSCD** Yang et al., 2007 
MSCs Cutaneous wound healing Azari et al., 2011 
Buffalo Embryonic stem cell Chondrogenic differentiation Sritanaudomchai et al., 
2013 
Monkey/ 
Primate 
Embryonic Stem Cell-Derived Neural Stem 
Cells 
Parkinson’s Disease Muramatsu et al., 2009 
Embryonic stem cells Dopaminergic neurons 
generation 
Takagi et al., 2005 
Avian/ 
Chicken 
Neural stem cells Reversal of neurobehavioral 
teratogenicity 
Dotan et al., 2010 
*AFTSD = Acute full-thickness skin defect; **LSCD = Limbal stem cell deficiency 
  
Prioritization of stem cell therapy in animals 
Animals in their course of life suffer from different 
diseases which are treated by different therapeutical 
approaches. Apart from looking after of own health, 
humans also gave intention towards the good health of pet 
and domesticated animals as these animals are supportive 
for them in different daily life activities and excellent source 
of food as well. Veterinary medicine is a branch of science, 
in which we study about body of animal and its functions, 
moreover study about different therapeutic techniques 
beneficial for preservation and improvement of animals 
health (Fortier and Travis, 2011). Different therapeutic 
approaches like chemotherapy, acupressure, curative 
magnetism, bone setting, homeopathy, osteopathy, 
phytotherapy are some of the practice used in veterinary 
clinics. Traditional veterinary medicines are also used for 
treatment of animals. In traditional veterinary medication, 
body of patient divided into different parts like a physical set 
of organs, muscles, joints, and tissue systems and 
treatment is given according to this division with surgery, 
drugs, chemicals or radiation. Variable side effects have 
been faced by animals due to variable toxic nature, trauma 
due to destructive effect of these therapeutical approaches 
of chemical, radiation and surgery. So, in case of traumatic 
emergencies to prevent brain edema different supportive 
treatments like usage of steroids, intravenous solution 
along other medicines are essential for saving life of 
patient. Apart from steroid, non-steroid anti-inflammatory 
drugs (NSAIDs) are used in animals suffer from 
osteoarthritis (OA) but data depict that use of NSAIDs 
several times do not give full pain aid in case of a lot of 
dogs affected with osteoarthritis (Black et al., 2008). 
From above mention literature it is clear that these 
traditional veterinary therapeutical approaches are time 
consuming and having some limitations in the form of side 
effects i.e. tumor formation etc. So, there is immense need 
of such therapeutical approaches which can overcome the 
shortcomings of these traditional veterinary practices. Stem 
cell therapy is excellent candidate for the treatment of 
veterinary diseases. Stem cells are multipotent and can 
differentiate into tendon, ligament, bone, cartilage, cardiac, 
nerve, muscle, blood vessels, fat, liver tissues etc. Clinical 
research on stem cell therapy demonstrated positive 
results in treating animals like horses with tendon and 
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ligament injuries, osteochondral defects and osteoarthritis. 
Likewise positive improvement in canines suffering with 
osteoarthritis of hip, defects of elbow and stifles have been 
reported (Verma et al., 2007). 
To date stem cell have been isolated from different 
sources, used for stem cell therapy, like bone marrow stem 
cells, AD-MSCs, mesoangioblast stem cells, infrapatellar 
fat pad derived MSCs, Hematopoietic stem cell, Epidermal 
stem cells, ESCs, neural stem cells, cardiac stem cells etc. 
Every type of stem cell mentioned above have its own 
benefits but AD-MSCs have been most successfully used 
in treatment of osteoarthritis, fractures, cerebral infarction, 
muscle dystrophy, autoimmune disorders etc. (Chen et al., 
2001; Murphy et al., 2003; El-Badri et al., 2004; Uccelli et 
al., 2006). These stem cell having functions including 
limiting anti-inflammatory responses and promote anti-
inflammatory pathways (Aggarwal and Pittenger, 2005) 
support angiogenesis, tissue remodeling, differentiation, 
and anti-apoptotic events by secreting bioactive level of 
cytokines and growth factors (Rehman  et al., 2004; 
Nakagami et al., 2006). Authors give preference to AD-
MSCs over traditional and regenerative cell derived from 
bone marrow because of their easy availability, can be 
collection in great concentration and contain 
heterogeneous mixture of MSCs, endothelial progenitor 
cells, immune cells, fibroblast etc. (Verma et al., 2007). 
Furthermore still no systematic adverse actions have been 
reported in case of AD-MSC therapy. These information 
are sufficient to conclude that stem cell therapy is safe and 
having significant place in treatment of veterinary diseases. 
  
Challenge, difficulties and ethical concerns in stem cell 
therapy 
Stem cell research provides therapeutic profit in the 
fields of remedial cloning and regenerative medicine. This 
research approach provides great prospective in healing 
and therapy of illness related to human being and animal 
species. With the advancement in stem cell research, 
scientists were able to develop diverse body parts in 
laboratories for the aid in healing of diseases. Scientists 
were capable to identify defects related to birth, sterility, 
reproduction related diseases and diseases of other body 
organs. Apart from benefits of stem cell therapy, there is a 
chapter of controversies related to stem cell therapy both in 
human and animal population. Problem of contamination 
during cell therapy is a big issue as any invisible transfer 
defector stem cell can produce tumor in recipient body. 
Transmission of communicable diseases like viral, bacterial 
etc. during stem cell therapy is of particular concern. 
Specialized cells which are used for cell therapies in 
animals must be tested several times in vitro and in vivo in 
suitable experimental or laboratory animals before their 
clinical practices to illustrate that they can repair regular 
physiological role in sick animal. Another issue related to 
cell therapy is of tissue rejection. Questions have risen 
related to politics and religion status of stem cell therapy. 
As political and religious disagreements about stem cell 
therapy are everywhere but severity of issue varies from 
country to country. 
 
CONCLUSION 
In conclusion, currently we are using stem cell therapy 
for the treatment of different diseases in valuable animals 
like racing horses (having good genetic traits), cats, dogs 
etc. We hope, in future we will be able to use these stem 
cell therapeutical approaches widely for the treatment of 
different diseases and disorders related to common food 
producing animals like buffalo, cow, sheep, goat etc. 
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